CAS 52232-67-4
:Teriparatida
Descrição:
Teriparatida é uma forma sintética do hormônio paratireoideano (PTH) usada principalmente no tratamento da osteoporose. É caracterizada pela sua capacidade de estimular a formação óssea, o que a torna distinta de outros tratamentos para osteoporose que se concentram principalmente na inibição da reabsorção óssea. Teriparatida é administrado por injeção subcutânea e geralmente é prescrito para pacientes com alto risco de fraturas. A substância é composta pelos primeiros 34 aminoácidos da PTH humana, que são cruciais para sua atividade biológica. Seu mecanismo de ação envolve a ligação aos receptores de PTH nos osteoblastos, promovendo o crescimento ósseo e aumentando a absorção de cálcio nos intestinos e rins. Teriparatida tem uma meia-vida relativamente curta, necessitando de administração diária para efeitos terapêuticos ideais. Efeitos colaterais comuns podem incluir náuseas, tontura e cãibras nas pernas. Devido aos seus efeitos anabólicos sobre o osso, Teriparatida é frequentemente considerado para uso em mulheres pós-menopáusicas e homens com osteoporose que têm histórico de fraturas ou perda óssea significativa.
Fórmula:C181H291N55O51S2・C2H4O<
InChI:InChI=1/C181H291N55O51S2/c1-21-96(18)146(236-160(267)114(48-53-141(250)251)212-174(281)132(84-239)232-177(284)143(93(12)13)233-147(254)103(185)82-237)178(285)216-111(45-50-134(187)241)155(262)219-119(65-90(6)7)163(270)213-116(55-62-289-20)158(265)224-124(71-100-79-196-86-203-100)167(274)226-126(73-135(188)242)169(276)217-117(63-88(2)3)148(255)201-81-138(245)205-105(39-27-30-56-182)149(256)223-123(70-99-78-195-85-202-99)166(273)221-121(67-92(10)11)164(271)225-128(75-137(190)244)171(278)231-131(83-238)173(280)214-115(54-61-288-19)157(264)210-112(46-51-139(246)247)153(260)208-109(43-34-60-199-181(193)194)159(266)234-144(94(14)15)175(282)215-113(47-52-140(248)249)156(263)222-122(69-98-77-200-104-38-26-25-37-102(98)104)165(272)220-120(66-91(8)9)161(268)209-108(42-33-59-198-180(191)192)151(258)206-106(40-28-31-57-183)150(257)207-107(41-29-32-58-184)152(259)218-118(64-89(4)5)162(269)211-110(44-49-133(186)240)154(261)228-129(76-142(252)253)172(279)235-145(95(16)17)176(283)229-125(72-101-80-197-87-204-101)168(275)227-127(74-136(189)243)170(277)230-130(179(286)287)68-97-35-23-22-24-36-97/h22-26,35-38,77-80,85-96,103,105-132,143-146,200,237-239H,21,27-34,39-76,81-84,182-185H2,1-20H3,(H2,186,240)(H2,187,241)(H2,188,242)(H2,189,243)(H2,190,244)(H,195,202)(H,196,203)(H,197,204)(H,201,255)(H,205,245)(H,206,258)(H,207,257)(H,208,260)(H,209,268)(H,210,264)(H,211,269)(H,212,281)(H,213,270)(H,214,280)(H,215,282)(H,216,285)(H,217,276)(H,218,259)(H,219,262)(H,220,272)(H,221,273)(H,222,263)(H,223,256)(H,224,265)(H,225,271)(H,226,274)(H,227,275)(H,228,261)(H,229,283)(H,230,277)(H,231,278)(H,232,284)(H,233,254)(H,234,266)(H,235,279)(H,236,267)(H,246,247)(H,248,249)(H,250,251)(H,252,253)(H,286,287)(H4,191,192,198)(H4,193,194,199)
SMILES:CCC(C)C(C(=NC(CCC(=N)O)C(=NC(CC(C)C)C(=NC(CCSC)C(=NC(Cc1cnc[nH]1)C(=NC(CC(=N)O)C(=NC(CC(C)C)C(=NCC(=NC(CCCCN)C(=NC(Cc1cnc[nH]1)C(=NC(CC(C)C)C(=NC(CC(=N)O)C(=NC(CO)C(=NC(CCSC)C(=NC(CCC(=O)O)C(=NC(CCCNC(=N)N)C(=NC(C(C)C)C(=NC(CCC(=O)O)C(=NC(Cc1c[nH]c2ccccc12)C(=NC(CC(C)C)C(=NC(CCCNC(=N)N)C(=NC(CCCCN)C(=NC(CCCCN)C(=NC(CC(C)C)C(=NC(CCC(=N)O)C(=NC(CC(=O)O)C(=NC(C(C)C)C(=NC(Cc1cnc[nH]1)C(=NC(CC(=N)O)C(=NC(Cc1ccccc1)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C(C(CCC(=O)O)N=C(C(CO)N=C(C(C(C)C)N=C(C(CO)N)O)O)O)O
Sinónimos:- Teriparatide Acetate
- Forteo
- L-Phenylalanine, L-seryl-L-valyl-L-seryl-L-alpha-glutamyl-L-isoleucyl-L-glutaminyl-L-leucyl-L-methionyl-L-histidyl-L-asparaginyl-L-leucylglycyl-L-lysyl-L-histidyl-L-leucyl-L-asparaginyl-L-seryl-L-methionyl-L-alpha-glutamyl-L-arginyl-L-valyl-L-alpha-glutamyl-L-tryptophyl-L-leucyl-L-arginyl-L-lysyl-L-lysyl-L-leucyl-L-glutaminyl-L-alpha-aspartyl-L-valyl-L-histidyl-L-asparaginyl-, acetate (salt) hydrate
- L-Seryl-L-valyl-L-seryl-L-alpha-glutamyl-L-isoleucyl-L-glutaminyl-L-leucyl-L-methionyl-L-histidyl-L-asparaginyl-L-leucylglycyl-L-lysyl-L-histidyl-L-leucyl-L-asparaginyl-L-seryl-L-methionyl-L-alpha-glutamyl-L-arginyl-L-valyl-L-alpha-glutamyl-L-tryptophyl-L-leucyl-L-arginyl-L-lysyl-L-lysyl-L-leucyl-L-glutaminyl-L-alpha-aspartyl-L-valyl-L-histidyl-L-asparaginyl-L-phenylalanine acetate (salt) hydrate
- Parathar
- Parathar acetate
- L-Phenylalanine, L-seryl-L-valyl-L-seryl-L-alpha-glutamyl-L-isoleucyl-L-glutaminyl-L-leucyl-L-methionyl-L-histidyl-L-asparaginyl-L-leucylglycyl-L-lysyl-L-histidyl-L-leucyl-L-asparaginyl-L-seryl-L-methionyl-L-alpha-glutamyl-L-arginyl-L-valyl-L-alpha-glutamyl-L-tryptophyl-L-leucyl-L-arginyl-L-lysyl-L-lysyl-L-leucyl-L-glutaminyl-L-alpha-aspartyl-L-valyl-L-histidyl-L-asparaginyl-, acetate (salt)
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
17 produtos.
Parathyroid Hormone (1-34), human
CAS:<p>Parathyroid Hormone (1-34), human</p>Fórmula:C181H291N55O51S2Peso molecular:4117.7pTH (1-34) (human)
CAS:Teriparatide, which consists of the N-terminal 34 amino acid residues of parathyroid hormone, shows the same potency and pharmacological profile as the native hormone. Administration of teriparatide stimulates bone formation and increases the bone mineral density (BMD).Fórmula:C181H291N55O51S2Pureza:99.1%Cor e Forma:WhitePeso molecular:4117.77pTH (1-34) (human)
CAS:Intermittent administration of teriparatide stimulates bone formation by increasing the number of osteoblasts. Agonist of the parathyroid hormone receptor PTH1.Fórmula:C181H291N55O51S2Pureza:96.3%Cor e Forma:WhitePeso molecular:4117.77TERIPARATIDE FOR SYSTEM SUITABILITY CRS
CAS:TERIPARATIDE FOR SYSTEM SUITABILITY CRSFórmula:C13H14ClNOPeso molecular:235.7094TERIPARATIDE CRS
CAS:TERIPARATIDE CRSFórmula:C13H14ClNOCor e Forma:Added AddedPeso molecular:235.7094Teriparatide
CAS:Polypeptide, protein and glycoprotein hormones, their derivatives and structural analogues, nesoiFórmula:C181H291N55O51S2Cor e Forma:White Off-White PowderPeso molecular:4115.13094Teriparatide
CAS:Teriparatide is an agonist of PHT(IC50 of 2 nM in HEK293 cells).Fórmula:C181H291N55O51S2Pureza:98%Cor e Forma:SolidPeso molecular:4117.72Parathyroid Hormone Fragment (1-34)- 24,d3 TFA Salt
CAS:Produto Controlado<p>Stability Hygroscopic<br>Applications Parathyroid Hormone Fragment (1-34)-24,d3,TFA Salt is the labeled (on Leucine-d3, position 24) analogue of Parathyroid Hormone Fragment (1-34) (P192200), which is a fragment of human parathyroid hormone (hPTH) peptide sequence containing the 34 N-terminal residues of hPTH. This fragment was also found to be an agonist at PTH1 and PTH2 receptors.<br>References Niall, et al.: Proc. Natl. Acad. Sci., 71, 384 (1974); Dobnig,T., et al.: Endocrinol., 138, 4607 (1997); Manabe. et al.: Bone., 40, 1475 (2007);<br></p>Fórmula:C181D3H288N55O51S2·xC2O2HF3Cor e Forma:NeatPeso molecular:4234.8Parathyroid Hormone Fragment (1-34)
CAS:Produto Controlado<p>Applications A fragment of human parathyroid hormone (hPTH) peptide sequence containing the 34 N-terminal residues of hPTH. This fragment was also found to be an agonist at PTH1 and PTH2 receptors.<br>References Niall, et al.: Proc. Natl. Acad. Sci., 71, 384 (1974); Dobnig,T., et al.: Endocrinol., 138, 4607 (1997); Manabe. et al.: Bone., 40, 1475 (2007);<br></p>Fórmula:C181H291N55O51S2Cor e Forma:NeatPeso molecular:4117.72Teriparatide-d10
CAS:Produto ControladoFórmula:C181D10H281N55O51S2Cor e Forma:NeatPeso molecular:4127.72Parathyroid Hormone (Human, 1-34)
CAS:<p>This product which is available as a 0.5mg vial is amino acids 1-34 of the 84 amino acid parathyroid hormone (PTH) and can be used as an adenylate cyclase and bone growth stimulating peptide. It is possible that in can be used in research in the treatments of some types of osteoporosis.<br>PTH is a peptide hormone that is secreted from the parathyroid gland in the event of abnormal serum calcium levels and it ultimately regulates calcium and phosphate levels in the body. The PTH exerts its activity through binding to the G-protein coupled receptor type 1 PTH receptor, which activates adenylate cyclase or phospholipase C thus activating pathways involved in the mediation of bone resorption and bone formation. This product is suitable for life science applications.</p>Fórmula:C181H291N55O51S2Pureza:Min. 95%Peso molecular:4,117.7 g/molTeripaRatide Acetate
CAS:<p>Custom research peptide; min purity 95%. For different specs please use the Peptide Quote Tool</p>Fórmula:C181H291N55O51S2Peso molecular:4,117.8 g/molParathyroid Hormone (Human, 1-34)
CAS:<p>This product which is available as a 0.1mg vial is amino acids 1-34 of the 84 amino acid parathyroid hormone (PTH) and can be used as an adenylate cyclase and bone growth stimulating peptide. It is also an effective anabolic agent used in the treatment of some forms of Osteoporosis.<br>PTH is a peptide hormone that is secreted from the parathyroid gland in the event of abnormal serum calcium levels and it ultimately regulates calcium and phosphate levels in the body. The PTH exerts its activity through binding to the G-protein coupled receptor type 1 PTH receptor, which activates adenylate cyclase or phospholipase C thus activating pathways involved in the mediation of bone resorption and bone formation. This product is suitable for life science applications.</p>Fórmula:C181H291N55O51S2Pureza:Min. 95%Peso molecular:4,117.7 g/mol











